These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9718021)

  • 21. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
    Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
    Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
    Eeles RA; Powles TJ
    J Clin Oncol; 2000 Nov; 18(21 Suppl):93S-9S. PubMed ID: 11060334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
    Hamann U
    Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer genetics: what we know and what we need.
    Nathanson KL; Wooster R; Weber BL
    Nat Med; 2001 May; 7(5):552-6. PubMed ID: 11329055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
    Vahteristo P; Eerola H; Tamminen A; Blomqvist C; Nevanlinna H
    Br J Cancer; 2001 Mar; 84(5):704-8. PubMed ID: 11237395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.
    Pääkkönen K; Sauramo S; Sarantaus L; Vahteristo P; Hartikainen A; Vehmanen P; Ignatius J; Ollikainen V; Kääriäinen H; Vauramo E; Nevanlinna H; Krahe R; Holli K; Kere J
    Genet Epidemiol; 2001 Feb; 20(2):239-46. PubMed ID: 11180449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rebbeck TR
    J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-expression profiles in hereditary breast cancer.
    Olopade OI; Grushko T
    N Engl J Med; 2001 Jun; 344(26):2028-9. PubMed ID: 11430337
    [No Abstract]   [Full Text] [Related]  

  • 29. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
    Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
    Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
    Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-expression profiles in hereditary breast cancer.
    Sudbø J; Reith A; Lingjaerde OC
    N Engl J Med; 2001 Jun; 344(26):2029. PubMed ID: 11430338
    [No Abstract]   [Full Text] [Related]  

  • 32. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
    Ligtenberg MJ; Hogervorst FB; Willems HW; Arts PJ; Brink G; Hageman S; Bosgoed EA; Van der Looij E; Rookus MA; Devilee P; Vos EM; Wigbout G; Struycken PM; Menko FH; Rutgers EJ; Hoefsloot EH; Mariman EC; Brunner HG; Van 't Veer LJ
    Br J Cancer; 1999 Mar; 79(9-10):1475-8. PubMed ID: 10188893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].
    Feunteun J
    C R Seances Soc Biol Fil; 1998; 192(2):235-40. PubMed ID: 9759367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited breast cancer: increasingly familiar territory.
    Garber J
    J Clin Oncol; 1998 May; 16(5):1639-41. PubMed ID: 9586872
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inherited breast cancer].
    Kaduri L; Heshing N; Abeliovich D; Peretz T
    Harefuah; 1996 Nov; 131(10):418-21. PubMed ID: 8981821
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic tests forge ahead, despite scientific concerns.
    Marshall A
    Nat Biotechnol; 1996 Dec; 14(13):1642-3. PubMed ID: 9634835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.